Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 2Neoplasms 2Venous Thromboembolism 1Pulmonary Embolism 1

Interventions

Dalteparin 8apixaban 6Rivaroxaban 6Heparin, Low-Molecular-Weight 5Tinzaparin 4Enoxaparin 4bemiparin 2abelacimab 2Warfarin 2MAA868 2Aspirin 2reviparin 1isoquercitrin 1edoxaban 1certoparin 1betrixaban 1argatroban 1acarboxyprothrombin 1Phenprocoumon 1Nadroparin 1N(4)-oleylcytosine arabinoside 1Dabigatran 1Acenocoumarol 1AVE 5026 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Venous Thromboembolism × edoxaban × Clear all
NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Daiichi Sankyo

Phase 3 Completed
1,046 enrolled 24 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡